Samsung C&T

Beta

KRX Filings & Disclosures 2026

Business Overview

• • Bio segment revenue KRW 5.95T (+31% YoY), operating profit KRW 2.19T (+69% YoY) — now largest profit contributor, overtaking construction
• • Samsung Biologics completed spin-off of Samsung Epis Holdings in Nov 2025, creating dedicated CDMO entity to eliminate biosimilar conflict-of-interest

Risk Factors

• • Listed equity portfolio KRW 44.75T (FY2025 vs KRW 21.68T FY2024); 1% price move = KRW 332.5B OCI impact
• • FX derivatives: 599 FX forward contracts at HQ alone across USD, EUR, JPY, CNY, KRW; group-wide total 1,150+ contracts across 13 subsidiaries

Management Discussion & Analysis

• • Bio segment revenue KRW 5.95T, up 30.9% YoY; operating profit KRW 2.19T, up KRW 895B — cited driver: Plant 4 full-scale operation driving production/sales volume increase
• • Consolidated operating profit KRW 3.29T, up 10.4% YoY despite revenue declining 3.2% to KRW 40.74T; operating margin improved to 8.1% from 7.1%

What are the latest Samsung C&T DART filings in 2026?

Samsung C&T (KRX code 028260) has filed an annual report on March 12, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Samsung C&T file its most recent annual report?

Samsung C&T filed its most recent annual report on March 12, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Samsung C&T's KRX stock code?

Samsung C&T's KRX stock code is 028260. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 028260 to look up all Samsung C&T disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Samsung C&T file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Samsung C&T.

Where can I find Samsung C&T financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Samsung C&T annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.